UBS’s Invesco Pharmaceuticals ETF PJP Stock Holding History

UBS’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$30.8M	Buy	483,745 +55,557	+13%	+$3.43M	0.02%	719
2014 Q2	$26.2M	Buy	428,188 +650	+0.2%	+$37.7K	0.02%	732
2014 Q1	$24.2M	Buy	427,538 +112,271	+36%	+$6.38M	0.02%	703
2013 Q4	$16.9M	Buy	315,267 +78,367	+33%	+$3.92M	0.02%	920
2013 Q3	$10.9M	Buy	236,900 +38,262	+19%	+$1.75M	0.01%	1070
2013 Q2	$8.39M	Buy	+198,638	New	+$8.27M	0.01%	1175

Other funds holding PJP

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

NCM

Niemann Capital Management Stateline, Nevada $788K AUM 23.27% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

FIG

FundX Investment Group San Francisco, California $411M AUM 22.05% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

SCM

Summit Capital Management Seattle, Washington $221M AUM 4.14% 1-Year Est. Return

UBS's PJP Position: Q3 2014 in Review

UBS increased its Invesco Pharmaceuticals ETF (PJP) stake by 13% in Q3 2014, buying an estimated $3.43M and bringing the position to 483,745 shares worth $30.8M. The position accounts for 0.02% of the portfolio, ranked #719.

UBS first reported a position in PJP in Q2 2013 and has held it in 6 quarters since. 90 funds tracked by Wall St. Rank hold PJP as of Q3 2014.

UBS held 483,745 shares of Invesco Pharmaceuticals ETF worth $30.8M as of Q3 2014.
UBS bought 55,557 Invesco Pharmaceuticals ETF shares in Q3 2014, an estimated $3.43M.
Invesco Pharmaceuticals ETF made up 0.02% of UBS's portfolio in Q3 2014, its #719 holding.
UBS first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and has held it in 6 quarters since.
90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.